Cafepharma Today

February 7 2025 - Novo Nordisk plans new study for CagriSema, targets 2026 submission
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Musk's team accesses Medicare, Medicaid records
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Bayer Antibiotic May Shorten Tuberculosis Treatment, Study Says
Bloomberg
Friday, April 3, 2009 - 9:08am
tags:
Bayer, antibiotics, tuberculosis, Avelox
[video] Celgene: A Broken Stock, Not a Broken Company
CNBC
Friday, April 3, 2009 - 9:06am
tags:
Celgene
Shire sues Natco over generic Fosrenol
Bizjournals.com
Friday, April 3, 2009 - 9:02am
tags:
Natco, Shire, generics, patents, Forsenol, kidney disease
At $18 Million, Abbott CEO’s Pay Tops Pfizer, Merck, J&J Chiefs
WSJ Online
Friday, April 3, 2009 - 8:57am
tags:
Pharma CEOs, Abbott Laboratories, Pfizer, Merck, JNJ
Bristol-Myers Cut at Bernstein on Lower Acquisition Potential
Bloomberg
Friday, April 3, 2009 - 7:39am
tags:
Bristol-Myers Squibb
Gilead Drug Lowers Blood Pressure in Trial
TheStreet.com
Friday, April 3, 2009 - 7:36am
tags:
Gilead Sciences, hypertension, antihypertensives, darusentan, drug trials
Rebooting the FDA
CNN Money
Friday, April 3, 2009 - 7:36am
tags:
FDA
Experts: Unknown tumor risk for Novo diabetes drug
Yahoo/AP
Friday, April 3, 2009 - 7:35am
tags:
cancer, diabetes, Novo Nordisk, liraglutide
Attack Of The Zombie Biotechs
Forbes
Friday, April 3, 2009 - 7:32am
tags:
biotech, Pfizer, Sutent
Options Action: Drug Firm Forest Sees Heavy Call Activity Amid Buyout Rumors
CNBC
Thursday, April 2, 2009 - 5:20pm
tags:
Forest Labs, buyouts
Merck to Benefit in SGP Deal
Yahoo/Zacks.com
Thursday, April 2, 2009 - 5:19pm
tags:
Merck, Schering Plough, buyouts, Remicade, JNJ
Pfizer's pipeline shrinks with research changes
Yahoo/AP
Thursday, April 2, 2009 - 5:18pm
tags:
Pfizer, pipelines, R&D
Nigeria lawyer: Clients awaiting notification of drug-study settlement by Pfizer
Chicago Tribune, IL
Thursday, April 2, 2009 - 5:17pm
tags:
Pfizer, Nigeria
Eisai signs agreement with Kissei Pharmaceutical for Urief
Trading Markets
Thursday, April 2, 2009 - 3:50pm
tags:
Eisai, Kissei, Urief
Prescription Abandonment Numbers on the Rise
PharmExec
Thursday, April 2, 2009 - 9:41am
tags:
prescription data
Celgene Breaking New Lows, But Hopefully Not Much Lower
Seeking Alpha
Thursday, April 2, 2009 - 9:37am
tags:
Celgene
Bristol-Myers climbs in pre-market trade on FDA nod
Marketwatch
Thursday, April 2, 2009 - 9:35am
tags:
FDA, Bristol-Myers Squibb, diabetes, Onglyza, AstraZeneca
Authors of Psychiatric Guidelines Get Funding from Drug Makers
WSJ Online
Thursday, April 2, 2009 - 9:31am
tags:
physician payments
Pfizer ends trial early for cancer drug Sutent
Yahoo/AP
Thursday, April 2, 2009 - 9:29am
tags:
Pfizer, Sutent, breast cancer, drug trials
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Seeking Alpha
Thursday, April 2, 2009 - 8:00am
tags:
biotech, Acorda Therapeutics, CV Therapeutics, Arena Pharmaceuticals, Genentech, Gilead Sciences, ZymoGenetics, ViroPharma, MAP Pharmaceuticals, Synta, La Jolla Pharmaceutical, Indevus, InterMune, Osiris Therapeutics

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information